Macron rolls out red carpet to JPMorgan, global CEOs in post-Brexit push
06/27/2021 23:22
PARIS (Reuters) - President Emmanuel Macron will declare that Paris is back on the map of global finance on Tuesday when he inaugurates JPMorgan s new trading hub in the French capital which he hopes will attract more bankers leaving post-Brexit Britain.
The U.S. bank s chief executive, Jamie Dimon, will be one of almost 120 international CEOs travelling to Versailles on Monday for Macron s now traditional Choose France summit in which he pitches France as an investment destination.
The day after, Dimon and Macron will visit JPMorgan s new hub in central Paris, a stone s throw away from the Louvre museum, where about 440 employees will be based, many having relocated from London.
Macron rolls out red carpet to JPMorgan, global CEOs in post-Brexit push
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Cerberus-backed My Money to buy HSBC French retail bank
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
HSBC to announce sale of French retail banking operations on Friday - sources
leaderpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leaderpost.com Daily Mail and Mail on Sunday newspapers.
2 Min Read
PARIS (Reuters) -Private equity firm PAI Partners is close to acquiring France’s SGD Pharma, a supplier of COVID-19 vaccine vials, from China Jianyin Investment (JIC), a source with direct knowledge of the transaction told Reuters.
The source said on Tuesday the deal would be submitted to antitrust authorities and employee representative bodies and require approval from China’s Finance Ministry.
The transaction, the source added, was expected to value SGD Pharma at around 10 times its core earnings, which stood at around 90 million euros ($109.15 million) last year.
SGD Pharma and Paris-based PAI Partners had no comment.
Reuters reported in March that SGD Pharma, which employs some 3,200 staff worldwide, was exploring options including a sale for more than 1 billion euros and that the business had been marketed to several buyout firms including PAI, Ardian, Eurazeo, CVC and Cinven.